MARKET

NTHI

NTHI

NeOnc Technologies Holdings Inc
NASDAQ
5.68
+0.07
+1.25%
After Hours: 5.68 0 0.00% 16:04 06/16 EDT
OPEN
6.23
PREV CLOSE
5.61
HIGH
6.23
LOW
5.52
VOLUME
9.85K
TURNOVER
--
52 WEEK HIGH
25.00
52 WEEK LOW
4.110
MARKET CAP
106.48M
P/E (TTM)
-2.2072
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NTHI last week (0609-0613)?
Weekly Report · 12h ago
NeOnc Technologies Appoints Dr. Josh Neman as CCO
TipRanks · 4d ago
NeOnc Technologies files to sell 10.02M shares of common stock by selling shareholders
Seeking Alpha · 06/09 17:18
NeOnc Technologies files to sell 10.02M shares of common stock for holders
TipRanks · 06/09 15:45
Weekly Report: what happened at NTHI last week (0602-0606)?
Weekly Report · 06/09 12:45
NeOnc Technologies Appoints New Chief Clinical Officer
TipRanks · 06/06 21:20
NeOnc Technologies Names Josh Neman CCO; Says Appointment Bolsters FDA Approval Path While Company Explores AI And Quantum Computing To Enhance Drug Delivery Platform
Benzinga · 06/06 13:07
NeOnc Technologies appoints Neman as CCO
TipRanks · 06/06 13:05
More
About NTHI
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on establishing treatments for intracranial malignancies, such as aggressive cancers located in the brain. It is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. It is developing novel drug delivery methods to be used in combination with novel drug candidates. The Company has two lead products in development: NEO100 and NEO212. NEO100 is a purified form of perillyl acid (POH) which is administered to brain cancer patients via intranasal delivery. NEO212 is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol. NEO212 is undergoing development towards intranasal application specifically for patients with uncontrolled brain metastases derived from peripheral tumors (lung, breast, skin, and others).

Webull offers Neonc Technologies Holdings Inc stock information, including NASDAQ: NTHI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTHI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTHI stock methods without spending real money on the virtual paper trading platform.